company

FARMATEKS (HOLDING) AS

1940 BJØRKELANGEN

Return on Equity
−31,57 %
Current Ratio
0,19
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue0
Net Income−227 000
Total Assets1 617 000
Total Equity719 000
Income (NOK)2022
Revenue0
Expenditure215 000
Operating Profit−215 000
Financial Income0
Financial Costs12 000
Financial Balance−12 000
Earnings Before Tax−227 000
Tax0
Net Income−227 000
Balance (NOK)2022
Total Fixed Assets1 442 000
Total Current Assets175 000
Total Assets1 617 000
Total Retained Equity−131 000
Total Equity719 000
Total Long-Term Debt0
Total Current Debt898 000
Total Equity and Debt1 617 000
Cash flow (NOK)2022
Sales Income0
Other Income0
Revenue0
Cost of Goods Sold0
Salary Costs0
Depreciation0
Impairment0
Expenditure215 000
Operating Profit−215 000
Financial Income0
Financial Costs12 000
Financial Balance−12 000
Dividends0
Net Income−227 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets1 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets1 440 000
Total Fixed Assets1 442 000
Stock0
Total Investments0
Cash, Bank0
Total Current Assets175 000
Total Assets1 617 000
Total Equity719 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors7 000
Unpaid Taxes0
Dividends0
Other Current Debt619 000
Total Current Debt898 000
Total Equity and Debt1 617 000
Financial indicators2022
Return on Equity−31,57 %
Debt-to-Equity Ratio0
Operating Profit Margin-
Current Ratio0,19
Quick Ratio0,19
Equity Ratio0,44
Gross Profit Margin-
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English